Opening Asia for Russia

Chinese-Uzbek development will be used in Uzbekistan for mass vaccination

03.03.2021 48 просмотров

In Uzbekistan, a Chinese-Uzbek vaccine against COVID-19 has been registered for use.


The Chinese-Uzbek development ZF-UZ-VAS 2001 is registered in Uzbekistan for mass use as a vaccine against coronavirus. This was announced on Monday by the press service of the Ministry of Innovative Development of the Republic.


“Today, the recombinant vaccine (CHO cells) ZF-UZ-VAC 2001 against a new type of coronavirus is registered for use in medical practice. Registration number DV/X 086/4603/21,” the message says.


Earlier it was reported that Uzbekistan, together with the Chinese company Zhifei Longcom, conducted the third phase of clinical trials of the ZF-2001 recombinant vaccine. Based on the test results, Uzbekistan was recognized as a co-author of the drug, which was named ZF-UZ-VAC 2001. It was also reported that in the near future the Uzbek company Jurabek Laboratories plans to start production of the Chinese-Uzbek vaccine on the territory of the republic.


According to the Ministry of Health and the Service for Sanitary and Epidemiological Welfare and Public Health, in Uzbekistan it is also planned to use the Russian Sputnik V vaccine for mass vaccination.


Новости партнёров